Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel H Wilks

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Scientific Reports|October 24, 2025
Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variantsAntonia Netzl, Sina Türeli, Eric B LeGresley, et al.
Vaccine|June 26, 2016
Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvantDavid L Gordon, Dimitar Sajkov, Yoshikazu Honda-Okubo, et al.
Cell Reports|January 4, 2025
Nonhuman primate antigenic cartography of SARS-CoV-2Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Nature Communications|August 26, 2023
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartographyAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
The Journal of Infectious Diseases|July 5, 2015
Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary InfectionJudith M Fonville, Pieter L A Fraaij, Gerrie de Mutsert, et al.
Nature Communications|December 13, 2022
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variantsAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
NPJ Vaccines|May 18, 2024
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster seraAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Mbio|August 11, 2023
Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolutionAdinda Kok, Rachel Scheuer, Theo M Bestebroer, et al.
Science Translational Medicine|November 30, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Biorxiv : the Preprint Server for Biology|August 31, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|October 24, 2025
Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variantsAntonia Netzl, Sina Türeli, Eric B LeGresley, et al.
Vaccine|June 26, 2016
Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvantDavid L Gordon, Dimitar Sajkov, Yoshikazu Honda-Okubo, et al.
Cell Reports|January 4, 2025
Nonhuman primate antigenic cartography of SARS-CoV-2Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Nature Communications|August 26, 2023
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartographyAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
The Journal of Infectious Diseases|July 5, 2015
Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary InfectionJudith M Fonville, Pieter L A Fraaij, Gerrie de Mutsert, et al.
Nature Communications|December 13, 2022
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variantsAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
NPJ Vaccines|May 18, 2024
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster seraAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Mbio|August 11, 2023
Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolutionAdinda Kok, Rachel Scheuer, Theo M Bestebroer, et al.
Science Translational Medicine|November 30, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Biorxiv : the Preprint Server for Biology|August 31, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Pageof 3